Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen]
Clinical trial NCT05060666 · UNKNOWN
Trial details
- NCT number
- NCT05060666
- Sponsor
- Infectopharm Arzneimittel GmbH
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2022-03-01
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.